Your browser doesn't support javascript.
loading
A review of the therapeutic potential of histone deacetylase inhibitors in rhabdomyosarcoma.
Selim, Omar; Song, Clara; Kumar, Amy; Phelan, Rebecca; Singh, Arun; Federman, Noah.
Affiliation
  • Selim O; Clinical and Translational Science Institute, University of California, Los Angeles, CA, United States.
  • Song C; Clinical and Translational Science Institute, University of California, Los Angeles, CA, United States.
  • Kumar A; Clinical and Translational Science Institute, University of California, Los Angeles, CA, United States.
  • Phelan R; Clinical and Translational Science Institute, University of California, Los Angeles, CA, United States.
  • Singh A; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, United States.
  • Federman N; Clinical and Translational Science Institute, University of California, Los Angeles, CA, United States.
Front Oncol ; 13: 1244035, 2023.
Article in En | MEDLINE | ID: mdl-37664028
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: Country of publication: